Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling

被引:21
作者
Chen, Fang [1 ]
Du, Yijuan [1 ]
Zhang, Zheng [1 ]
Chen, Gang [1 ]
Zhang, Min [1 ]
Shu, Hong-Bing [2 ]
Zhai, Zhonghe [1 ]
Chen, Danying [1 ]
机构
[1] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China
[2] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
IL-1R; TLR4; TRAF6; syntenin; NF-kappa B;
D O I
10.1016/j.cellsig.2007.12.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Toll-like receptors are involved in host defense against invading pathogens. The two members of this superfamily, IL-1R and TLR4, activate overlapping NF-kappa B activate signaling pathway mediated by TRAF6. In this study, we identified Syntenin as a negative regulator of IL-1R and TLR4 mediated NF-kappa B activation. Overexpressed Syntenin inhibited IL-1- or LPS-, but not TNF- induced NF-kappa B activation and IL-8 mRNA expression in a dose dependent manner. Syntenin specifically interacted with TRAF6 in human 293 cells, and inhibited TRAF6 induced NF-kappa B and AP-1 activation. Syntenin also associated with TRAF6 under physiological condition, and dissociated from TRAF6 upon IL-1 stimulation. This might be due to a competition between syntenin and IRAK1, as overexpression of IRAK1 disrupted the interaction of Syntenin with TRAF6, and rescued Syntenin induced reduction of TRAF6 ubiquitination. Moreover, knockdown of Syntenin potentiated IL-1- or LPS- triggered NF-kappa B activation and IL-8 mRNA expression. These findings suggest that Syntenin is a physiological suppressor of TRAF6 and plays an inhibitory role in IL-1R- and TLR4- mediated NF-kappa B activation pathways. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:666 / 674
页数:9
相关论文
共 35 条
[1]   mda-9/syntenin:: A positive regulator of melanoma metastasis (Publication with Expression of Concern. See vol. 79, pg. 5127, 2019) [J].
Boukerche, H ;
Su, ZZ ;
Emdad, L ;
Baril, P ;
Balme, B ;
Thomas, L ;
Randolph, A ;
Valerie, K ;
Sarkar, D ;
Fisher, PB .
CANCER RESEARCH, 2005, 65 (23) :10901-10911
[2]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[3]   A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-κB activation [J].
Chen, DY ;
Li, XY ;
Zhai, ZH ;
Shu, HB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :15985-15991
[4]   Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[5]  
Chung JY, 2002, J CELL SCI, V115, P679
[6]   Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain [J].
Deng, L ;
Wang, C ;
Spencer, E ;
Yang, LY ;
Braun, A ;
You, JX ;
Slaughter, C ;
Pickart, C ;
Chen, ZJ .
CELL, 2000, 103 (02) :351-361
[7]  
FEMANDEZLARREA J, 1999, MOL CELL, V3, P423
[8]   Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction [J].
Fitzgerald, KA ;
Palsson-McDermott, EM ;
Bowie, AG ;
Jefferies, CA ;
Mansell, AS ;
Brady, G ;
Brint, E ;
Dunne, A ;
Gray, P ;
Harte, MT ;
McMurray, D ;
Smith, DE ;
Sims, JE ;
Bird, TA ;
O'Neill, LAJ .
NATURE, 2001, 413 (6851) :78-83
[9]   Cytokine-specific transcriptional regulation through an IL-5Rα interacting protein [J].
Geijsen, N ;
Uings, IJ ;
Pals, C ;
Armstrong, J ;
McKinnon, M ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
Coffer, PJ .
SCIENCE, 2001, 293 (5532) :1136-1138
[10]   The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains [J].
Gimferrer, I ;
Ibáñez, A ;
Farnós, M ;
Sarrias, MR ;
Fenutría, R ;
Roselló, S ;
Zimmermann, P ;
David, G ;
Vives, J ;
Serra-Pagès, C ;
Lozano, F .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1406-1414